Company intelligence / Profile preview

Pooyesh Darou

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Pooyesh Darou has commercialized at least 6 recombinant biopharmaceutical products in Iran and the Middle East, leveraging exclusive technology from the ICGEB to manufacture protein therapeutics, marking them as a regional leader and innovator in biotechnology.[1][2][4][5][6]

Therapeutic areas: Other
Modalities: Recombinant proteinBiologic
Industry: Biotech

Drug pipeline

2 assets

PDgrastim

1 more asset in the full pipeline.

Partnerships

International Center for Genetic Engineering and Biotechnology (ICGEB)Tehran University of Medical Sciences (TUMS)Primm Labs (Milan, Italy)National Institute for Biological Standards and Control (NIBSC, UK)

Beyond the preview

Go deeper on Pooyesh Darou.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pooyesh Darou.